Progress in the development of new drugs in Alzheimer's disease.
Alzheimer's disease (AD) is an age-related neurodegenerative disease with a global prevalence estimated at 26.55 million in 2006. During the past decades, several agents have been approved that enhance cognition of AD patients. However, the effectiveness of these treatments are limited or controversial and they do not modify disease progression. Recent advances in understanding AD pathogenesis have led to the development of numerous compounds that might modify the disease process. AD is mainly characterized neuropathologically by the presence of two kinds of protein aggregates: extracellular plaques of Abeta-peptide and intracellular neurofibrillary tangles. Abeta and tau could interfere in an original way contributing to a cascade of events leading to neuronal death and transmitter deficits. Investigation for novel therapeutic approaches targeting the presumed underlying pathogenic mechanisms is major focus of research. Antiamyloid agents targeting production, accumulation, clearance, or toxicity associated with Abeta peptide, are some approaches under investigation to limit extracellular plaques of Abeta-peptide accumulation. We can state as an example: Abeta passive and active immunization, secretases modulation, Abeta degradation enhancement, or antiaggregation and antifibrillization agents. Tau-related therapies are also under clinical investigation but few compounds are available. Another alternative approach under development is neuroprotective agents such as antioxidants, anti-inflammatory drugs, compounds acting against glutamate mediated neurotoxicity. Neurorestorative approaches through neurotrophin or cell therapy also represent a minor avenue in AD research. Finally, statins, receptor for advanced glycation end products inhibitors, thiazolidinediones, insulin, and hormonal therapies are some other ways of research for a therapeutic approach of Alzheimer's disease. Taking into account AD complexity, it becomes clear that polypharmacology with drugs targeting different sites could be the future treatment approach and a majority of the recent drugs under evaluation seems to act on multiple targets. This article exposes general classes of disease-modifying therapies under investigation.
Gérontopôle, Hôpitaux de Toulouse, France. piau.a@chu-toulouse.fr
Antoine
A
Piau
F
F
Nourhashémi
C
C
Hein
C
C
Caillaud
B
B
Vellas
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D018450:Disease Progression; D055808:Drug Discovery; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016875:tau Proteins / Q000378:metabolism*
D016229:Amyloid beta-Peptides; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018696:Neuroprotective Agents; D016875:tau Proteins
Cell Mol Neurobiol. 2002 Feb;22(1):13-24
12064514
Dement Geriatr Cogn Disord. 2004;18(2):217-26
15237280
Brain Pathol. 1999 Jan;9(1):133-46
9989456
Curr Alzheimer Res. 2005 Dec;2(5):541-51
16375657
Am J Pathol. 2007 May;170(5):1669-75
17456772
Life Sci. 2001 Apr 27;68(22-23):2593-600
11392631
IDrugs. 2007 Jun;10(6):399-412
17642004
Exp Neurol. 2001 Jan;167(1):158-65
11161603
Neurology. 2005 May 10;64(9):1553-62
15883316
J Clin Invest. 2004 May;113(10):1384-7
15146234
Cochrane Database Syst Rev. 2017 Apr 18;4:CD002854
28418065
Neurology. 2005 Apr 12;64(7):1152-6
15824339
Neurology. 2008 Sep 30;71(14):1065-71
18401020
Neurodegener Dis. 2007;4(5):392-402
17536186
Annu Rev Pharmacol Toxicol. 2003;43:545-84
12415125
Arch Neurol. 2005 May;62(5):753-7
15883262
J Alzheimers Dis. 2001 Feb;3(1):65-73
12214074
Med Hypotheses. 2007;68(5):1088-92
17107752
J Biol Chem. 2004 Mar 26;279(13):12876-82
14709552
Neurobiol Aging. 2006 Feb;27(2):318-23
16399214
N Engl J Med. 1997 Apr 24;336(17):1216-22
9110909
Lancet Neurol. 2010 Jul;9(7):702-16
20610346
Curr Alzheimer Res. 2005 Jul;2(3):281-90
15974893
Neurology. 2004 Jan 27;62(2):275-80
14745067
J Pharmacol Exp Ther. 2005 Sep;314(3):1274-89
15951399
J Neurosci. 2001 Apr 15;21(8):2561-70
11306609
J Alzheimers Dis. 2008 Jun;14(2):225-34
18560133
Neurology. 2005 Jun 28;64(12):2063-8
15985573
Ann N Y Acad Sci. 2008 Apr;1126:147-51
18448809
Nature. 1999 Jul 8;400(6740):173-7
10408445
Neurobiol Dis. 2003 Dec;14(3):458-69
14678762
CNS Drugs. 2005;19(12):989-96
16332141
Neurology. 2001 Jul 10;57(1):80-8
11445632
Nat Med. 2005 Apr;11(4):434-9
15778722
Ann Neurol. 2002 Sep;52(3):346-50
12205648
Eur J Neurosci. 2007 Jan;25(1):59-68
17241267
J Neurosci. 2003 Mar 15;23(6):1992-6
12657655
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12197-202
12213959
Neuron. 2006 Mar 2;49(5):671-82
16504943
J Neuroinflammation. 2007 Sep 04;4:21
17784957
Alzheimer Dis Assoc Disord. 2006 Apr-Jun;20(2 Suppl 1):S19-26
16772752
Neurology. 2008 Feb 5;70(6):440-8
17942819
Nat Med. 2005 May;11(5):551-5
15852017
Arch Neurol. 2006 Feb;63(2):177-85
16344336
Pharmacogenomics J. 2006 Jan-Feb;6(1):8-15
16314887
Exp Gerontol. 2004 Nov-Dec;39(11-12):1641-9
15582280
JAMA. 2002 Jun 26;287(24):3223-9
12076218
Neuroepidemiology. 1992;11(3):163-8
1407253
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005592
18425924
Lancet Neurol. 2008 Sep;7(9):779-86
18672400
Neurology. 2000 Mar 28;54(6):1265-72
10746596
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD005380
18254079
J Neurosci. 2006 Aug 30;26(35):9047-56
16943563
Lancet. 2000 Nov 11;356(9242):1627-31
11089820
Clin Med Res. 2007 Oct;5(3):177-83
18056027
Neurobiol Aging. 2005 Feb;26(2):157-63
15582745
J Mol Neurosci. 2003;20(3):349-56
14501019
J Clin Epidemiol. 2003 Apr;56(4):367-76
12767414
Nat Med. 2000 Aug;6(8):916-9
10932230
CNS Drugs. 2003;17(1):27-45
12467491
Neuroscience. 2000;101(3):485-512
11113299
Cochrane Database Syst Rev. 2002;(2):CD003673
12076498
Expert Opin Investig Drugs. 2007 Jul;16(7):1087-97
17594192
Curr Drug Targets. 2007 May;8(5):621-32
17504105
Drugs Today (Barc). 2006 May;42(5):291-8
16801992
Life Sci. 2003 Jun 20;73(5):539-53
12770610
Neurodegener Dis. 2007;4(6):443-86
17934328
J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1472-4
15377700
J Anat. 2000 Nov;197 Pt 4:553-62
11197528
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12432-7
12205295
Neurology. 2008 Nov 18;71(21):1702-8
19015485
J Med Chem. 1997 Jan 31;40(3):385-90
9022806
Curr Alzheimer Res. 2006 Apr;3(2):123-7
16611012
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1941-6
11172055
Lancet Neurol. 2007 Apr;6(4):373-8
17362841
Biochim Biophys Acta. 2005 Sep 25;1741(3):246-52
16051470
Neurosci Lett. 2008 Mar 21;434(1):93-8
18289787
Neurology. 2008 Jan 1;70(1):17-24
18003940
Neurology. 2007 Mar 27;68(13):1008-12
17389305
CNS Spectr. 2007 Jan;12(1):62-8
17192765
Neurobiol Aging. 1989 Sep-Oct;10(5):593-602
2554168
Science. 2002 Jul 19;297(5580):353-6
12130773
CNS Drug Rev. 2002 Fall;8(3):255-82
12353058
Pharmacopsychiatry. 2003 Nov;36(6):297-303
14663654
Brain Res. 2001 Nov 16;919(1):115-21
11689168
Nat Neurosci. 2001 Mar;4(3):231-2
11224535
Curr Alzheimer Res. 2008 Apr;5(2):212-24
18393806
Curr Alzheimer Res. 2007 Apr;4(2):147-52
17430239
Cochrane Database Syst Rev. 2002;(3):CD000147
12137606
Neurology. 2007 Sep 4;69(10):1012-7
17785670
Alzheimers Dement. 2007 Jul;3(3):186-91
19595937
J Neural Transm (Vienna). 2003 Jul;110(7):789-801
12811639
Nature. 2003 May 22;423(6938):435-9
12761548
CNS Drug Rev. 2004 Summer;10(2):167-82
15179445
J Mol Neurosci. 2006;30(1-2):19-20
17192610
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003154
16625572
Clin Neuropharmacol. 2007 Nov-Dec;30(6):317-25
18090456
Arch Neurol. 2006 May;63(5):686-92
16533956
Panminerva Med. 2006 Jun;48(2):87-96
16953146
Nature. 2000 Dec 21-28;408(6815):982-5
11140686
Neurology. 2007 Nov 13;69(20):1921-30
17998483
Neurology. 2003 Jul 8;61(1):46-54
12847155
Ann Pharmacother. 2005 Dec;39(12):2073-80
16227450
Alzheimer Dis Assoc Disord. 1995;9 Suppl 2:50-61
8534424
Neuron. 2003 May 22;38(4):547-54
12765607
JAMA. 2008 Oct 15;300(15):1774-83
18854539
J Alzheimers Dis. 2006 Sep;10(1):43-51
16988481
Arch Neurol. 2003 Dec;60(12):1685-91
14676042
Science. 2008 Apr 25;320(5875):520-3
18436784
J Alzheimers Dis. 2006 Aug;9(4):393-8
16917147
Neurobiol Aging. 2007 Apr;28(4):537-47
16675063
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593
16437532
J Neuroinflammation. 2008 Jan 09;5:2
18184433
Neurology. 2000 Jan 25;54(2):421-6
10668706
N Engl J Med. 2001 Nov 22;345(21):1515-21
11794217
Curr Alzheimer Res. 2007 Jul;4(3):253-62
17627482
N Engl J Med. 2007 Jun 14;356(24):2457-71
17517853
J Psychopharmacol. 2007 Mar;21(2):171-8
17329297
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8850-5
11438712
NeuroRx. 2004 Apr;1(2):213-25
15717022
Mol Membr Biol. 2006 Jan-Feb;23(1):111-22
16611586
J Alzheimers Dis. 2003 Jun;5(3):229-39
12897407
J Biol Chem. 1997 Oct 3;272(40):25326-32
9312151
Neurobiol Aging. 2006 Jul;27(7):909-17
15979211
Mt Sinai J Med. 2006 Nov;73(7):931-40
17195878
Endocrine. 2005 Apr;26(3):317-26
16034187
Neurobiol Dis. 2007 Apr;26(1):273-81
17321748
Drugs R D. 2006;7(3):187-93
16752944
JAMA. 2003 Jun 4;289(21):2819-26
12783912
Behav Brain Res. 2005 Apr 30;159(2):295-300
15817192
Dement Geriatr Cogn Disord. 2000 Jul-Aug;11(4):230-7
10867450
J Med Chem. 2005 May 19;48(10):3467-70
15887953
Arch Intern Med. 2002 Oct 14;162(18):2046-52
12374512
J Neuropathol Exp Neurol. 2006 Jul;65(7):631-41
16825950
Curr Alzheimer Res. 2006 Dec;3(5):541-50
17168653
Endocrine. 2003 Oct;22(1):41-8
14610297
Clin Neuropharmacol. 2005 May-Jun;28(3):126-32
15965311
Curr Alzheimer Res. 2005 Jul;2(3):307-18
15974896
Neurology. 1993 Aug;43(8):1609-11
8351023
Neurology. 2002 May 14;58(9):1436
12011303
IDrugs. 2007 Feb;10(2):121-33
17285465
Curr Alzheimer Res. 2005 Jan;2(1):79-95
15977991
Curr Opin Mol Ther. 2005 Feb;7(1):17-23
15732525
Arch Neurol. 2003 Jul;60(7):940-6
12873849
Neuropharmacology. 2007 Nov;53(6):699-723
17904591
Crit Rev Immunol. 2008;28(2):109-26
18540827
Mol Cell Endocrinol. 2007 Jan 2;260-262:271-5
17052835
Curr Opin Investig Drugs. 2002 May;3(5):768-73
12090551
Drugs Today (Barc). 2003 Jan;39(1):75-83
12669110
Neurobiol Aging. 2004 Mar;25(3):311-4
15123336
Arch Neurol. 2006 Oct;63(10):1402-8
17030655
Neurochem Res. 2007 Apr-May;32(4-5):739-50
17191138
Curr Opin Investig Drugs. 2008 Jul;9(7):735-43
18600579
Am J Cardiol. 2007 Jun 18;99(12A):112i-122i
17599421
Am J Clin Nutr. 2004 Nov;80(5):1194-200
15531665
J Neurochem. 2007 Aug;102(3):753-60
17504266
JAMA. 2005 Mar 16;293(11):1338-47
15769967
J Neurosci Res. 2002 Nov 1;70(3):514-8
12391612
Biochim Biophys Acta. 2006 Feb;1760(2):200-6
16309845
Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11141-6
15263077
Exp Neurol. 2001 Sep;171(1):29-45
11520119
Dement Geriatr Cogn Disord. 2007;23(1):8-21
17068392
J Mol Neurosci. 2004;24(1):105-13
15314258
Curr Alzheimer Res. 2005 Jul;2(3):335-41
15974899
Ann N Y Acad Sci. 2001 Jun;939:425-35
11462798
Eur J Neurol. 2006 Sep;13(9):981-5
16930364
Neurology. 2006 Nov 28;67(10):1757-63
17082468
J Gerontol A Biol Sci Med Sci. 2003 Apr;58(4):372-7
12663701
Lancet Neurol. 2008 Jun;7(6):483-93
18450517
J Neurochem. 2001 Jan;76(1):173-81
11145990
J Neurosci. 2007 Feb 21;27(8):1981-91
17314294
Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1463-70
18655815
Lancet. 2008 Jul 19;372(9634):207-15
18640457
Am J Epidemiol. 2004 May 15;159(10):959-67
15128608
J Pharmacol Exp Ther. 2007 Jan;320(1):386-96
17003227
J Pharmacol Exp Ther. 2007 Jun;321(3):1032-45
17327487
J Cell Mol Med. 2008 Jan-Feb;12(1):38-55
18194444
Pharmacol Ther. 2005 Nov;108(2):129-48
16112736
Ann Intern Med. 2008 Mar 4;148(5):379-97
18316756
Neurosignals. 2005;14(1-2):71-82
15956816
Mayo Clin Proc. 2001 Sep;76(9):906-9
11560301
Ann Intern Med. 2005 Jan 4;142(1):37-46
15537682
Subcell Biochem. 2005;38:235-54
15709482
PLoS One. 2008 Jan 23;3(1):e1475
18213383
J Pharmacol Exp Ther. 1996 Dec;279(3):1422-9
8968367
Int J Neuropsychopharmacol. 2006 Feb;9(1):101-24
16083515
Neurobiol Aging. 2004 Nov-Dec;25(10):1315-21
15465629
Eur J Pharmacol. 2000 Dec 1;409(1):45-55
11099699
J Neural Transm (Vienna). 2005 Mar;112(3):429-53
15723159
JAMA. 1998 Mar 4;279(9):688-95
9496988
Neurology. 1992 Mar;42(3 Pt 1):631-9
1549228
Drugs Aging. 2007;24(2):107-19
17313199
J Neurosci. 2005 Sep 28;25(39):8898-902
16192379
Neurology. 2005 Jan 25;64(2):290-6
15668427
Neurochem Res. 2007 Aug;32(8):1329-35
17401652
Ann Neurol. 2008 May;63(5):621-31
18300284
Amyloid. 2003 Mar;10(1):1-6
12762134
Curr Alzheimer Res. 2006 Feb;3(1):71-3
16472206
Alzheimers Dement. 2008 Mar;4(2):145-53
18631958
Brain Res. 2003 Apr 25;970(1-2):221-5
12706264
Cochrane Database Syst Rev. 2003;(2):CD004031
12804498
Curr Drug Targets. 2006 Nov;7(11):1389-97
17100579
Neuron. 2003 Dec 18;40(6):1087-93
14687544
J Neurochem. 2007 Feb;100(3):802-9
17156133
J Am Geriatr Soc. 2003 Aug;51(8):1143-8
12890080
Neurotox Res. 2005;7(4):293-318
16179266
Lancet Neurol. 2003 Jul;2(7):425-8
12849121
Mol Cell Neurosci. 2005 Jun;29(2):333-43
15911356
Psychopharmacology (Berl). 2009 Jan;202(1-3):53-65
19005644
Arch Neurol. 2004 Jan;61(1):82-8
14732624
J Neurosci. 2005 Jan 19;25(3):629-36
15659599
J Alzheimers Dis. 2007 Sep;12(2):195-206
17917164
Am J Pathol. 2005 Jun;166(6):1761-71
15920161
Clin Pharmacol Ther. 2008 Jan;83(1):86-96
17507923
Neurology. 2002 Sep 24;59(6):880-6
12297571
Best Pract Res Clin Endocrinol Metab. 2003 Mar;17(1):105-22
12763515
Geriatrics. 2004 Jun;59(6):22-7
15224791
Am J Alzheimers Dis Other Demen. 2008 Apr-May;23(2):192-9
18198237
Curr Alzheimer Res. 2005 Apr;2(2):125-9
15974908
Neurodegener Dis. 2008;5(3-4):194-6
18322388
Pharmacol Biochem Behav. 2006 Oct;85(2):298-306
17045636
J Neuropathol Exp Neurol. 2001 Aug;60(8):759-67
11487050
Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):541-52
16266287
Trends Pharmacol Sci. 2006 Dec;27(12):619-25
17056129
J Am Geriatr Soc. 2000 Oct;48(10):1183-94
11037003
Trends Biochem Sci. 2004 Oct;29(10):548-55
15450610
Neuroscience. 2002;115(1):201-11
12401334
Behav Brain Res. 2000 Aug;113(1-2):169-81
10942043
Eur J Pharmacol. 2005 Dec 19;527(1-3):111-20
16325809
Drugs R D. 2006;7(2):87-97
16542055
Acta Pharmacol Sin. 2006 Jan;27(1):41-9
16364209
Br J Pharmacol. 1999 May;127(1):139-44
10369466
J Mol Neurosci. 2001 Oct;17(2):171-81
11816790
Am J Geriatr Psychiatry. 2005 Nov;13(11):950-8
16286438
J Neurosci. 2001 Jun 15;21(12):4183-7
11404403
Neuron. 1994 Jul;13(1):45-53
8043280
Cell Cycle. 2008 Apr 15;7(8):1020-35
18414053
J Biol Chem. 2005 Feb 18;280(7):5892-901
15590663
Neurology. 2006 Feb 28;66(4):602-4
16505324
Neurology. 2004 Jan 13;62(1):66-71
14718699
J Mol Neurosci. 2002 Aug-Oct;19(1-2):187-93
12212779
J Neural Transm Suppl. 2007;(72):189-93
17982894
J Alzheimers Dis. 2006 Sep;10(1):81-7
16988485
Int J Clin Pract. 2003 Jan-Feb;57(1):36-9
12587940
Pharmacol Ther. 2007 Jan;113(1):154-64
16989905
Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8754-9
18559859
J Alzheimers Dis. 2006;9(3 Suppl):219-42
16914861